Beyond BRAF: where next for melanoma therapy?

por Fedorenko, I V, Gibney, G T, Sondak, V K, Smalley, K S M
Publicado 2015

Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy

por Paraiso, K H T, Fedorenko, I V, Cantini, L P, Munko, A C, Hall, M, Sondak, V K, Messina, J L, Flaherty, K T, Smalley, K S M
Publicado 2010